Literature DB >> 16598090

Residual nonunion following vascularised fibular graft treatment for congenital pseudarthrosis of the tibia: a report of two cases.

A R Sulaiman1, S Nordin, W I Faisham, W Zulmi, A S Halim.   

Abstract

Resection and reconstruction using a vascularised fibular graft is a viable alternative treatment for congenital pseudarthrosis of the tibia, although distal junctional nonunion and residual deformity are known complications that are difficult to treat. We illustrate 2 cases in which bony union was achieved following a technique using fibular grafting and intramedullary nailing, without additional bone grafting. This technique was feasible because of hypertrophy of the fibular graft.

Entities:  

Mesh:

Year:  2006        PMID: 16598090     DOI: 10.1177/230949900601400114

Source DB:  PubMed          Journal:  J Orthop Surg (Hong Kong)        ISSN: 1022-5536            Impact factor:   1.118


  4 in total

Review 1.  Prevalence of neurofibromatosis type 1 in congenital pseudarthrosis of the tibia.

Authors:  Kjell Van Royen; Hilde Brems; Eric Legius; Johan Lammens; Armand Laumen
Journal:  Eur J Pediatr       Date:  2016-08-12       Impact factor: 3.183

2.  Secondary Knee Osteoarthritis due to Neurofibromatosis Type 1 Treated with above the Knee Amputation: A Case Report.

Authors:  Jay Patel; Jeffrey Whiting; Daniel Jones
Journal:  Case Rep Orthop       Date:  2013-07-07

3.  Repair of segmental load-bearing bone defect by autologous mesenchymal stem cells and plasma-derived fibrin impregnated ceramic block results in early recovery of limb function.

Authors:  Min Hwei Ng; Suryasmi Duski; Kok Keong Tan; Mohd Reusmaazran Yusof; Kiat Cheong Low; Isa Mohamed Rose; Zahiah Mohamed; Aminuddin Bin Saim; Ruszymah Bt Hj Idrus
Journal:  Biomed Res Int       Date:  2014-07-08       Impact factor: 3.411

4.  Orthopaedic manifestations of neurofibromatosis type 1: A case report.

Authors:  Florentina Năstase; Diana Sabina Radaschin; Elena Niculeț; Andrei Vlad Brădeanu; Mădălina Codruța Verenca; Aurel Nechita; Valentin Chioncel; Lawrence Chukwudi Nwabudike; Liliana Baroiu; Eduard Drima Polea; Silvia Fotea; Lucretia Anghel; Alexandru Nechifor; Alin Laurenţiu Tatu
Journal:  Exp Ther Med       Date:  2021-12-13       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.